Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a month

Despite the Sensex falling 561 points on Tuesday, four BSE 150 Midcap stocks—The Phoenix Mills, Ipca Laboratories, Laurus Labs and Biocon—scaled fresh 52-week highs, signalling strong buying interest and sustained bullish momentum amid broader market weakness.